Pleural mesothelioma (PM), a rare malignant tumor explicitly
associated
with asbestos and erionite exposures, has become a global health problem
due to limited treatment options and a poor prognosis, in which the
median life expectancy varies depending on the method of treatment.
However, the importance of early diagnosis is emphasized, and the
practical methods have not matured yet. This study provides a critical
overview of PM, addressing various aspects like epidemiology, etiology,
diagnosis, treatment options, and the potential use of advanced technologies
like microfluidic chip-based models for research and diagnosis. It
initially begins with fundamentals of clinical aspects and then discusses
the identification of disease-specific biomarkers in patients’
serum or plasma samples, which could potentially be used for early
diagnosis. A detailed investigation of the sophisticated preclinical
models is highlighted. Recent three-dimensional (3D) model accomplishments,
including microarchitecture modeling by transwell coculture, spheroids,
organoids, 3D bioprinting constructs, and ex vivo tumor slices, are discussed comprehensively. On-chip models that
imitate physiological processes, such as detection chips and therapeutic
screening chips, are assessed as potential techniques. The review
concludes with a critical and constructive discussion of the growing
interest in the topic and its limitations and suggestions.